1910's ITO™ platform orchestrates multimodal AI and lab automation for small and large molecule drug discovery.
ITO™ (Intelligent Therapeutics Orchestrator) is 1910's end-to-end AI infrastructure for pharmaceutical R&D.
It unifies generative models, predictive ADMET tools, and high-throughput biological automation in a closed feedback loop, enabling partners to advance programs from target identification to lead optimization across small molecules, peptides, and proteins.
Genesis Therapeutics
GEMS AI Platform
genesistherapeutics.ai
Insilico Medicine
Pharma.ai
insilico.com
Recursion Pharmaceuticals
Recursion OS
recursion.com
| Attribute | ITO Platform | GEMS AI Platform | Pharma.ai | Recursion OS | |
|---|---|---|---|---|---|
| Provider | | | | | |
| Founded | 2018 | 2019 | 2014 | 2013 | |
| Sells To | Enterprise, Pharmaceutical | Enterprise | Enterprise | Enterprise | |
| Pricing Model | Licensing | Recurring, Software | Recurring, Software | Recurring, Software | |
| Ownership | Venture-backed | Venture-backed | Venture-backed | Public, Venture-backed |
Provider
Founded 2018
Sells To Enterprise, Pharmaceutical
Pricing Model Licensing
Ownership Venture-backed
Provider
Founded 2019
Sells To Enterprise
Pricing Model Recurring, Software
Ownership Venture-backed
Provider
Founded 2014
Sells To Enterprise
Pricing Model Recurring, Software
Ownership Venture-backed
Provider
Founded 2013
Sells To Enterprise
Pricing Model Recurring, Software
Ownership Public, Venture-backed
AI-enabled natural-product drug discovery platform organizing plant chemistry into a searchable library with machine-learning translation and automated screening.
Biology-First AI platform predicts disease-matched compounds using multi-omics human data and functional validation.
A tissue-first platform generating spatial, molecular, and functional maps from patient tumors.
Creation uses Lila Iris and AI Science Factories to generate validated scientific assets and company opportunities.
Catalyst gives partner science teams direct platform access to Lila Iris and AI Science Factories.
Isomorphic Labs' Drug Design Engine builds on AlphaFold to predict biomolecular structures for drug discovery.
Machine learning platform for drug discovery and development.
AI-enabled natural-product drug discovery platform organizing plant chemistry into a searchable library with machine-learning translation and automated screening.
Biology-First AI platform predicts disease-matched compounds using multi-omics human data and functional validation.
A tissue-first platform generating spatial, molecular, and functional maps from patient tumors.
Creation uses Lila Iris and AI Science Factories to generate validated scientific assets and company opportunities.
Catalyst gives partner science teams direct platform access to Lila Iris and AI Science Factories.
Isomorphic Labs' Drug Design Engine builds on AlphaFold to predict biomolecular structures for drug discovery.
